Swertiamarin
Cat. No.：YN1720023
CAS No. ：17388-39-5
| 产品名称: | Swertiamarin |
| CAS No.: | 17388-39-5 |
| Chemical Name: | (4aR,5R,6S)-5-ethenyl-6-(β-D-glucopyranosyloxy)-4,4a,5,6-tetrahydro-4a-hydroxy-1H,3H-pyrano[3,4-c]pyran-1-one |
| Synonyms: | 獐牙菜苦苷 |
| 分子量: | 374.34 |
| 分子式: | C₁₆H₂₂O₁₀ |
| SMILES: | C=C[C@@H]([C@@H]1O[C@]([C@@H]([C@@H](O)[C@@H]2O)O)([H])O[C@@H]2CO)[C@@](C3=CO1)(CCOC3=O)O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Swertiamarin 是一种在Enicostemma Species属植物中发现的裂环烯醚萜苷，具有降血糖和降血脂的作用。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Vaijanathappa, J., and Badami, S.Antiedematogenic and free radical scavenging activity of swertiamarin isolated from Enicostemma axillarePlanta Med.75(1),12-17(2009)
Saravanan, S., Islam, V.I., Thirugnanasambantham, K., et al.Swertiamarin ameliorates inflammation and osteoclastogenesis intermediates in IL-1β induced rat fibroblast-like synoviocytesInflamm. Res.63(6),451-462(2014)
Sonawane, R.D., Vishwakarma, S.L., Lakshmi, S., et al.Amelioration of STZ-induced type 1 diabetic nephropathy by aqueous extract of Enicostemma littorale Blume and swertiamarin in ratsMol. Cell Biochem.340(1-2),1-6(2010)
Patel, T.P., Rawal, K., Soni, S., et al.Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosisBiomed. Pharmacother.83,785-791(2016)
Yang, Y., Li, J., Wei, C., et al.Amelioration of nonalcoholic fatty liver disease by swertiamarin in fructose-fed micePhytomedicine59,152782(2019)
